Altimmune, Inc.

ALTNASDAQHealthcare● Active

$2.73

+$0.02(+0.55%)

Market Cap$240501143

P/E Ratio—

52W High$7.73

52W Low$2.56

Avg Volume4.0M

Open$2.75

Beta0.23

Overview

Altimmune, Inc. (ALT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ALT · net income · updated Jun 8, 2026

Core profitability metrics

ALT · net income · margin · TTM · CAGR

Net income was −$88.1M for FY2025 (fiscal year ending 2025-12-31), up 7.3% year-over-year. Net profit margin was -214861.0%. Based on available data, Altimmune, Inc. has been profitable since at least 2016.

FY2025 Net Income−$88.1M▲ +7.3% YoY

Trailing 12M (TTM)−$91.1Mtrailing 4 quarters sum

Net Profit Margin< −999%−$88.1M ÷ $41,000

YoY Change+7.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2016

▸ FMP /income-statement · Annual · ALT net income history · ALT profit margin

Annual net income data

ALT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$88.1M▲ +7.3%-214861.0%$41,000

FY2024Loss−$95.1M▼ 7.5%-475295.0%$20,000

FY2023Loss−$88.4M▼ 4.4%-20762.2%$426,000

FY2022Loss−$84.7M▲ +12.7%—−$68,000

FY2021Loss−$97.1M▼ 98.0%-2201.6%$4.4M

Net income vs peers (Healthcare)

ALT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Altimmune, Inc.YOU

ALT

−$88.1M+7.3%-214861.0%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Altimmune, Inc. (ALT) reported net income of −$88.1M for FY2025 (fiscal year ending 2025-12-31), up 7.3% year-over-year. The net profit margin was -214861.0% — meaning the company kept $-2148.61 of every dollar of revenue as profit.

Based on available data, Altimmune, Inc. has been profitable since at least 2016. Net income reached a peak of $193.9M in FY2016. Data available for 15 fiscal years.

Altimmune, Inc.'s net profit margin was -214861.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Altimmune, Inc. net worth" — the company's market capitalization is a separate figure from ALT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ALT net income · 4 questions

Altimmune, Inc. is not currently profitable on an annual basis. The company reported a net loss of $88.1M for FY2025.

is ALT profitabledoes ALT make a profitALT profitabilityALT profitable company

▸ Source: FMP /income-statement · GAAP · Altimmune, Inc. · Altimmune, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026